Tucotuzumab celmoleukin

Tucotuzumab celmoleukin Uses, Dosage, Side Effects, Food Interaction and all others data.

Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment).

Trade Name Tucotuzumab celmoleukin
Generic Tucotuzumab celmoleukin
Tucotuzumab celmoleukin Other Names Tucotuzumab celmoleukin
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Tucotuzumab celmoleukin
Tucotuzumab celmoleukin

Innovators Monograph

You find simplified version here Tucotuzumab celmoleukin

*** Taking medicines without doctor's advice can cause long-term problems.
Share